Ming Xian

CIK 1743879 · View on SEC EDGAR ↗

Insider

First SEC filing: July 6, 2020 · Latest: July 6, 2020

On this page

Insider at

Insider transactions

0 buys (P) 0 sells (S) Net: $0 + 5 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

Date Ticker Code Shares Price Value Owned after Δ own A/D vs now
Aug. 8, 2022 MED A 7 $138.78 $971 1,954 Direct +0.36% Acquired -91.7% (price as of 2026-08-20)
June 16, 2022 MED A 1,317 1,947 Direct +209.05% Acquired (price as of 2026-08-20)
June 3, 2021 MED A 630 2,751 Direct +29.70% Acquired (price as of 2026-08-20)
July 2, 2020 MED A 1,083 2,121 Direct +104.34% Acquired (price as of 2026-08-20)
Feb. 22, 2019 MED A 1,038 1,038 Direct Acquired (price as of 2026-08-20)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II)

Options, RSUs and convertible securities reported on Form 4 Table II.

Date Ticker Security Underlying Exercise price Expiration Shares A/D
Aug. 8, 2022 MED Restricted Stock Units (cash settled) Common Stock (7) 7 Acquired
June 16, 2022 MED Restricted Stock Units (cash settled) Common Stock (1,317) 1,317 Acquired
June 3, 2021 MED Restricted Stock Units (cash settled) Common Stock (630) 630 Acquired
July 2, 2020 MED Restricted Stock Units (cash settled) Common Stock (1,083) 1,083 Acquired
Feb. 22, 2019 MED Restricted Stock Units (cash settled) Common Stock (1,038) 1,038 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).